Literature DB >> 10749381

Exfoliation syndrome and exfoliation glaucoma.

E Vesti1, T Kivelä.   

Abstract

Exfoliation syndrome abnormal deposition in the anterior segment of the eye of an unknown substance thought to be related to elastic fibres and basement membrane components is associated with accelerated cataract progression. increased frequency of intraoperative and postoperative complications and increased risk for glaucoma and. therefore, is a clinically important finding. A clear association has been shown with age. The syndrome occurs worldwide but its prevalence seems to vary from country to country. The best-known sign of exfoliation syndrome is deposits of greyish-white material on the anterior lens surface. Sometimes exfoliation material can also be seen at the pupillary border, on the anterior iris surface, corneal endothelium, and on the anterior vitreous face. When clinically detected, exfoliation syndrome is somewhat more often unilateral than bilateral. According to recent investigations clinically unilateral exfoliation syndrome is probably never truly unilateral but rather asymmetric, because exfoliation material has been detected ultrastructurally and immunohistochemically around iris blood vessels of the nonexfoliative fellow eyes. Indeed, electron microscopy identifies in various organs of patients with exfoliation syndrome fibrils similar to those seen in intraocular exfoliation deposits. Other clinical signs associated with exfoliation syndrome are pigment dispersion, transillumination defects of the iris and reduced response to mydriatics. In unilateral exfoliation syndrome, intraocular pressure (IOP) of the exfoliative eye is approximately 2 mmHg higher than IOP of the nonexfoliative fellow eye. Whether elevated IOP, vascular changes or exfoliation syndrome itself is the main factor causing optic nerve head damage and conversion of an exfoliative eye to glaucomatous, is not known. Glaucoma in the exfoliation syndrome has been shown to have a more serious clinical course than in primary open-angle glaucoma (POAG). At the time of diagnosis, IOP and its diurnal variation are generally higher and visual field defects tend to be greater in exfoliation glaucoma than in POAG. Because the decrease in lOP variation and lowering of the mean IOP level has been shown to improve visual field prognosis more in exfoliation glaucoma than in POAG, the glaucomatous process is considered to be more pressure-related in exfoliation glaucoma. Furthermore, progression of optic disc damage has been shown to be similar in exfoliation glaucoma and POAG when lOPs are lowered to a comparable level by the treatment. However, vascular disturbances in the posterior segment of the eye might after all be of equal importance in these two types of glaucoma; optic disc haemorrhages and venous occlusions have been reported to be as frequent in exfoliation glaucoma as in POAG. Perhaps in exfoliation glaucoma circullatory disturbances combined with high IOP lead to a particularly relentlessly progressing form of the disease.

Entities:  

Mesh:

Year:  2000        PMID: 10749381     DOI: 10.1016/s1350-9462(99)00019-1

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  40 in total

1.  Detecting protein aggregates on untreated human tissue samples by atomic force microscopy recognition imaging.

Authors:  Rhiannon Creasey; Shiwani Sharma; Jamie E Craig; Christopher T Gibson; Andreas Ebner; Peter Hinterdorfer; Nicolas H Voelcker
Journal:  Biophys J       Date:  2010-09-08       Impact factor: 4.033

2.  Nailfold capillary morphology in exfoliation syndrome.

Authors:  C C Cousins; J H Kang; C Bovee; J Wang; S H Greenstein; A Turalba; L Q Shen; S Brauner; T Boumenna; S Blum; H Levkovitch-Verbin; R Ritch; J L Wiggs; P A Knepper; L R Pasquale
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

3.  Hemodynamic evaluation of the posterior ciliary circulation in exfoliation syndrome and exfoliation glaucoma.

Authors:  Efstathios T Detorakis; Athanassios K Achtaropoulos; Eleni E Drakonaki; Vassilios P Kozobolis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-17       Impact factor: 3.117

4.  A Comparison of Resource Use and Costs of Caring for Patients With Exfoliation Syndrome Glaucoma Versus Primary Open-Angle Glaucoma.

Authors:  Siddarth Rathi; Chris Andrews; David S Greenfield; Joshua D Stein
Journal:  Am J Ophthalmol       Date:  2019-01-08       Impact factor: 5.258

5.  Correlation between intraocular pressure obtained with water drinking test versus modified diurnal tension curve measurement in pseudoexfoliation glaucoma.

Authors:  Penpe Gül Firat; Seyhan Dikci; İlknur Tuncer Firat; Soner Demirel; Murat Firat; Emrah Öztürk; Zarife Ekici Gök
Journal:  Int Ophthalmol       Date:  2021-04-20       Impact factor: 2.031

6.  Association of tumor necrosis factor alpha gene polymorphism G-308A with pseudoexfoliative glaucoma in the Pakistani population.

Authors:  Muhammad Imran Khan; Shazia Micheal; Noreen Rana; Farah Akhtar; Anneke I den Hollander; Asifa Ahmed; Raheel Qamar
Journal:  Mol Vis       Date:  2009-12-22       Impact factor: 2.367

7.  Serum YKL-40 levels as a novel marker of inflammation and endothelial dysfunction in patients with pseudoexfoliation syndrome.

Authors:  K Türkyılmaz; V Öner; A Kırbas; M S Sevim; B Sekeryapan; G Özgür; M Durmus
Journal:  Eye (Lond)       Date:  2013-05-10       Impact factor: 3.775

8.  Alzheimer's peptide and serine proteinase inhibitors in glaucoma and exfoliation syndrome.

Authors:  Sabina Janciauskiene; Torsten Krakau
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

9.  Comparison of long-term results of trabeculectomy to treat pseudoexfoliative glaucoma and primary open angle glaucoma.

Authors:  Vuslat Pelitli Gürlü; Hande Güçlü; Altan Özal; Ömer Benian; Levent Alimgil
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

10.  Evaluation of LOXL1 polymorphisms in exfoliation syndrome in a Chinese population.

Authors:  Ling Chen; Liyun Jia; Ningli Wang; Guangxian Tang; Chun Zhang; Sujie Fan; Wenru Liu; Hailin Meng; Wotan Zeng; Ningpu Liu; Huaizhou Wang; Hongyan Jia
Journal:  Mol Vis       Date:  2009-11-14       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.